Fundraising Fox
Canurta Therapeutics
2 known investors
Find your way into Canurta Therapeutics
Sign up to see every warm intro you have to Canurta Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Canurta Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Canurta develops novel botanical drug candidates, starting with rare polyphenols, using an AI discovery engine that guides compound identification, optimization, GMP-compliant production, and blockchain-based traceability. The company targets disease pathways such as inflammation, oxidative stress, and neurodegeneration (including ALS) across its therapeutic pipeline.
Founders & leadership
AG
Akeem GardnerFounder · Chief Executive OfficerAkeem Gardner holds degrees in psychology, philosophy, and law, and founded Canurta Therapeutics five years ago after beginning work in botanical hemp cultivation for inflammation-related applications.
Investors · 2
Frequently asked questions
- What does Canurta Therapeutics do?
- Canurta develops novel botanical drug candidates, starting with rare polyphenols, using an AI discovery engine that guides compound identification, optimization, GMP-compliant production, and blockchain-based traceability. The company targets disease pathways such as inflammation, oxidative stress, and neurodegeneration (including ALS) across its therapeutic pipeline.
- Who founded Canurta Therapeutics?
- Canurta Therapeutics was founded by Akeem Gardner.
- Who are Canurta Therapeutics's investors?
- Canurta Therapeutics's investors include Innovative Solutions Canada, Waterloo Accelerator Centre.